Bybit, the world's second-largest cryptocurrency exchange by trading volume, has launched a fully sponsored market literacy ...

The Capitals will continue navigating the challenges and advantages that come with a multi-school roster. For many of the ...

WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response ...

(Nasdaq: OKTA), the leading independent identity partner, today announced that its board of directors approved a share repurchase program with authorization to purchase up to $1 billion of its Class A ...

Weight Watchers, through its affiliated Weight Watchers Clinic, is a NovoCare ® Recognized Care Provider based on its demonstrated ability to deliver FDA-approved GLP-1 medications alongside expert ...

Worst Cooks in America returns for season 30 as cast and crew reflect on Anne Burrell’s legacy, share memories, and explain how the show moves forward ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...